human papillomavirus

Girls Who Get HPV Vaccine Still Practice Safe Sex (CME/CE)

MedPage Today Infectious Disease  Wed, 01/04/2012 - 07:00

(MedPage Today) -- Most girls who receive the human papillomavirus (HPV) vaccine don't take it as a license for riskier sexual behavior, researchers reported.


 

US patent awarded for Rochester's pioneering HPV vaccine work

EurekAlert! - Cancer  Mon, 11/21/2011 - 23:00

(University of Rochester Medical Center) The University of Rochester has been awarded a US patent for research essential to both human papillomavirus vaccines on the market.

The patent is for the creation of virus-like particles that mimic HPV 16, the type of HPV that causes the majority of all cancers related to HPV.


 

AASLD: High-Risk HPV Seen in Low-Risk Liver Tx Patients (CME/CE)

MedPage Today Infectious Disease  Sun, 11/06/2011 - 16:00

SAN FRANCISCO (MedPage Today) -- A substantial proportion of women evaluated for liver transplant had coexisting infection with the hepatitis C virus and high-risk human papillomavirus, investigators reported here.


 

HPV Vaccine Cuts Risk of Anal Pre-Cancers (CME/CE)

MedPage Today Infectious Disease  Wed, 10/26/2011 - 15:00

(MedPage Today) -- Among men who have sex with men, the vaccine against human papillomavirus (HPV) reduces the risk of the precursors of anal cancer, researchers reported.


 

Panel recommends HPV shot in boys

BBC News | Health | World Edition  Tue, 10/25/2011 - 18:14

A US government medical panel recommends the human papillomavirus vaccine for boys, as vaccination rates for young women stagnate.


 

CDC Committee Backs HPV Vaccine for Boys

MedPage Today Infectious Disease  Tue, 10/25/2011 - 13:10

(MedPage Today) -- The CDC's Advisory Committee on Immunization Practices has approved draft recommendations for routine vaccination of 11- and 12-year-old boys with Gardasil to protect against four strains of the human papillomavirus (HPV).


 

Three HPV Vax Doses May Be Overkill (CME/CE)

MedPage Today Infectious Disease  Thu, 09/08/2011 - 14:56

(MedPage Today) -- Two doses of a bivalent vaccine against human papillomavirus (HPV) appeared just as effective in preventing persistent infections as the recommended three doses in young women, according to a study in Costa Rica.